Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Virtual Preceptorship on Hereditary Cancer Genetics 2021

Start date
27 May 2021
End date
27 May 2021
Virtual, CEST Time

Learning objectives

  • To learn about the best clinical practice in the multidisciplinary management of hereditary cancer syndromes     
  • To understand the molecular basis and heterogeneity of the genetic susceptibility to develop cancer   
  • To learn how to recognize, diagnose, treat and provide prevention recommendations to patients with a germline genetic susceptibility

Download the programme


The programme of this virtual event has been accredited with​ ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.



  • Judith Balmaña, Spain
  • Nicoline Hoogerbrugge, Netherlands

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.